Results 141 to 150 of about 39,109 (302)

Balloon‐Expandable Versus Self‐Expanding Valves in Bicuspid Aortic Stenosis: Insights From the SWEDEHEART Registry

open access: yesCatheterization and Cardiovascular Interventions, Volume 106, Issue 4, Page 2336-2347, October 1, 2025.
ABSTRACT Background Transcatheter aortic valve replacement (TAVR) is increasingly used in patients with bicuspid aortic valve (BAV) stenosis, but there is limited comparative data on balloon‐expandable (BEV) versus self‐expanding valves (SEV) in this population. Aim To compare clinical and hemodynamic outcomes between BEVs and SEVs in patients with BAV
Antros Louca   +13 more
wiley   +1 more source

Feasibility and Safety of Transfemoral Aortic Valve Replacement Using Local Anesthesia in the Catheterization Suite Versus General Anesthesia in the Operation Theater

open access: yesCatheterization and Cardiovascular Interventions, Volume 106, Issue 4, Page 2454-2468, October 1, 2025.
ABSTRACT Background For over a decade, transfemoral transcatheter aortic valve replacements (TF‐TAVR) have been performed at the University Hospital of Nancy. A minimalistic approach to TF‐TAVR, conducted without general anesthesia and entirely percutaneously in a catheterization suite (simplified approach), has been reported to be as safe and ...
Guillaume Abadié   +8 more
wiley   +1 more source

Pattern of Cardiovascular Diseases Among Elderly Patients Admitted in Medical Wards at Muhimbili National Hospital Dar es salaam Tanzania [PDF]

open access: yes, 2011
Cardiovascular disease is the most frequent cause of death in persons over the age 50 years and most importantly it is responsible for considerable morbidity and large burden of disability in the community. Cardiovascular diseases are an increasing cause
Kisenge, Peter Richard
core  

Two‐Year Results of Percutaneous Endocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy

open access: yesCatheterization and Cardiovascular Interventions, Volume 106, Issue 4, Page 2763-2769, October 1, 2025.
ABSTRACT Background Hypertrophic obstructive cardiomyopathy (HOCM) is a hereditary myocardial disease. Percutaneous endocardial septal radiofrequency ablation (PESA) is an innovative approach for treating HOCM. Consequently, we present the outcomes of the PESA for HOCM. Methods This study included 20 patients with HOCM who received PESA.
NingNing Zheng   +6 more
wiley   +1 more source

High-grade mitral valve insufficiency after fracture of the Mitrofix prosthesis [PDF]

open access: bronze, 2011
Robert von Wattenwyl   +2 more
openalex   +1 more source

PROLIDASE LEVEL IN CORONARY ARTERY DISEASE AND ISCHEMIC MITRAL VALVE INSUFFICIENCY

open access: gold, 2023
Vedat AĞRIÇ   +6 more
openalex   +1 more source

Administration of Nebulized Nitroglycerin Inhalation Combined With Subarachnoid Anesthesia for Cesarean Delivery With Pulmonary Arterial Hypertension: A Case Report

open access: yesClinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT In patients with severe pulmonary hypertension, nebulized nitroglycerin inhalation combined with subarachnoid anesthesia is a safe anesthetic option for cesarean section. It maintains stable hemodynamics and, by decreasing pulmonary artery pressure, prevents right heart failure.
Lian Xin   +5 more
wiley   +1 more source

Giant Left Atrial Myxoma Prolapsed To Left Ventricule With Every Cardiac Cyclus Operated With Biatrial Transseptal Incision

open access: yesSakarya Tıp Dergisi, 2015
Primary cardiac tumors are rarely seen.Most of the intracardiac tumors are benign characterised and mainly seen benign cardiac tumor is myxoma.Our patient was 40 years old woman.She is referring with dyspnea complaint to the Chest Diseases clinic for ...
Alper Erkin   +3 more
doaj  

Conception et développement d'un banc d'essai afin d'évaluer les différentes techniques de réparation de la valve mitrale [PDF]

open access: yes, 2015
L'insuffisance mitrale (IM), définie comme le reflux de sang du ventricule gauche vers l'oreillette gauche en phase de systole ventriculaire, est une affection fréquente, touchant env. 2% de la population européenne [1-2].
VEDANI, S
core  

Home - About - Disclaimer - Privacy